254
Views
15
CrossRef citations to date
0
Altmetric
Obesity

Impact of Obesity on the Severity and Therapeutic Responsiveness of Acute Episodes of Asthma

, M.D., , M.ED., , M.S., , M.D., , M.D., , M.D. & , M.D. show all
Pages 546-552 | Published online: 23 May 2011
 

Abstract

Background. It has been suggested that obesity adversely influences both the severity and the therapeutic responsiveness of chronic asthma. However, it is unclear if it also impacts acute situations. Methods. To determine whether adiposity worsens the clinical and physiological manifestations of acute asthma and limits therapeutic effectiveness of standard treatment, we contrasted signs, symptoms, medication use, arterial oxygen saturation, peak expiratory flow rate, and the bronchodilator response to standard doses of albuterol in 90 non-obese and 90 obese asthmatics as they presented for urgent care. Treatment and clinical decisions were systematized using published care paths and the peak flow was measured with standard techniques. Body mass index (BMI) was calculated according to consensus criteria. Results. Other than BMI (p < .001), there were no between-group differences in age, gender, race, signs, symptoms, pulse oximetry, or pre-presentation medication use. The pretreatment peak flow in the obese population was 22.4% higher on average (p = .007), but there were no differences in the distribution of severity (p = .38), the response to albuterol (p = .61), or admission–discharge ratios (p = .62). Conclusions. Obesity does not adversely influence the severity or the resolution of acute episodes of asthma.

Acknowledgments

Supported in part by Grant HL33791 and HL04140 from the National Heart, Lung, and Blood Institute, United States Public Health Services. Dr. McFadden has received grants from NIH and has served as a reviewer for NHLBI and NAID. He is currently the principal investigator on an investigator-initiated study supported by GlaxoSmithKline that deals with the genetics of B2 adrenergic receptors in acutely ill asthmatics who fail emergency therapy with albuterol. He has also received honorarium from MERCK.

Declaration of Interest

The authors report no conflicts of interests. The authors alone are responsible for the content and writing of this article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,078.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.